Navigation Links
MiMedx Group, Inc. Announces Release Date for 2013 First Quarter Results
Date:4/16/2013

KENNESAW, Ga., April 16, 2013 /PRNewswire/ -- MiMedx Group, Inc. (OTC: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that its results for the first quarter ended March 31, 2013, will be released before the opening of the market on Wednesday, May 1, 2013. MiMedx will host a live broadcast of its first quarter conference call on Wednesday, May 1, 2013 at 10:30 AM EDT. A listen-only simulcast of the MiMedx Group conference call will be available online at the Company's website at www.mimedx.com or at www.earnings.com. A 30-day online replay will be available approximately one hour following the conclusion of the live broadcast. The replay can also be found on the Company's website at www.mimedx.com or www.earnings.com.

About the Company

MiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. "Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include the device technologies HydroFix® and CollaFix™, and our tissue technologies, AmnioFix® and EpiFix®. Our tissue technologies are processed from human amniotic membrane that is derived from the donated placentas. Through our donor program, mothers delivering full-term Caesarean section births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. We process the human amniotic membrane utilizing our proprietary Purion® Process, to produce a safe, effective and minimally manipulated implant for homologous use. MiMedx® is the leading supplier of amniotic tissue, having supplied over 140,000 allografts to date to distributors and OEMs for application in the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental sectors of healthcare.


'/>"/>
SOURCE MiMedx Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. MiMedx Responds To Inquiries Regarding Trading Activity; Reiterates First Quarter And Full Year Goals
2. MiMedx to Present at the Canaccord Genuity Musculoskeletal Conference
3. MiMedx Is Issued Four Additional U.S. Patents For Placental Tissue Grafts
4. MiMedx Group, Inc. Announces Release Date for 2012 Fourth Quarter Results
5. MiMedx Group to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
6. MiMedx Group Announces Record Third Quarter Results And Raises Revenue Estimates For The Year
7. MiMedx Group to Present at the Craig-Hallum 2012 Alpha Select Conference
8. MiMedx Group to Present at the BIOX; Noble Financial Capital Markets Life Sciences Exposition
9. MiMedx Group Raises over $4.9 Million through the Exercise of Callable Warrants
10. MiMedx Group to Present at the Canaccord Genuity Annual Growth Conference
11. MiMedx Group Announces Record Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... The ... hobbyists, and the University Aviation Association (UAA), the unifying voice for collegiate aviation ... Challenge will encourage teamwork, competition, and success through a STEM-based education platform. , ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... specialists DST Diagnostische Systeme & Technologien GmbH, thereby expanding its product portfolio to ... from hay fever, urticaria, asthma, atopic eczema or a food allergy. Allergies are ...
(Date:6/22/2017)... ... 22, 2017 , ... The first human cell line HeLa, established in 1951, ... on cross-contamination of human cell lines with HeLa cells were published. Until recently, cross-contamination ... labs and is associated with dramatic consequences for research. , In this educational ...
(Date:6/20/2017)... ... 20, 2017 , ... Biologist Dawn Maslar MS has found a biomarker that ... Chase, Women Choose: The Neuroscience of Meeting, Dating, Losing Your Mind, and Finding True ... ”The logical next step, in my estimation, was to scientifically track the evidence of ...
Breaking Biology Technology:
(Date:4/13/2017)... , April 13, 2017 UBM,s Advanced Design ... will feature emerging and evolving technology through its ... Summits will run alongside the expo portion of the ... panels and demonstrations focused on trending topics within 3D ... design and manufacturing event will take place June 13-15, 2017 ...
(Date:4/11/2017)... , April 11, 2017 NXT-ID, ... security technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate ... ... NXT-ID, we look forward to their guidance and benefiting from ...
(Date:4/4/2017)... 2017   EyeLock LLC , a leader of ... States Patent and Trademark Office (USPTO) has issued U.S. ... of an iris image with a face image acquired ... company,s 45 th issued patent. ... given the multi-modal biometric capabilities that have recently come ...
Breaking Biology News(10 mins):